A new research report by Transparency Market Research (TMR) presents a comprehensive overview as well as an unbiased analysis of the global market for anti-tumor drugs. The study is titled “Anti-Tumor Drugs Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019.”

Get Free Sample Research Report:

A tumor, also known as a neoplasm, is caused by an unusual proliferation of tissues. It is broadly classified as a benign tumor and a malignant tumor. A malignant tumor is cancerous in nature while a benign tumor possesses the potential to turn into a malignant one. The increasing incidence of the malignant tumor is propelling the demand for anti-tumor drugs in the global arena. According to the WHO, by the end of 2025, the number of patients suffering from cancer would reach 15 million globally. Going by the prediction, the worldwide anti-tumor drugs market is likely to witness exponentially increasing demand for these drugs over the next few years.

In addition to this, governments and various non-governmental organizations in several economies are getting concerned over the alarming rate of mortality due to cancer across the world and have taken various initiatives to encourage the development of anti-tumor as well as anti-cancer drugs. This factor, along with the increased government funding for research and development activities in this field, also leads to the significant growth of the global anti-tumor drugs in the near future.

According to the report, the future of the global anti-tumor market looks thriving. However, various side-effects such as hair loss, weakness, nausea, allergies, and other dermatological side effects of these drugs are likely to restrict the market’s growth in the coming years.

Anti-tumor drugs help in limiting the growth of tumor cells by regulating the level of hormones in these cells. Various anti-tumor drugs mentioned in this market report are idarucicin, daunorubicin, citomycin D, doxorubicin, epirubicin, bleomycin, mitoxantrone, and mitomycin.

Additionally, alkaloids, used as anti-tumors drugs, such as irinotecan, etoposide, topotecan, vinorelbine, vinblastine, streptozocin, chlorambucil, ifosfamide, cyclophosphamide, melphalan, paclitaxel, vincristine, bendamustine, temozolomide, dacarbazine, busulfan, procarbazine, carmustine, and docetaxel, are also mentioned in this study.

The report also maps the competitive landscape of the global anti-tumor drugs market by assessing the company profiles of the key market players. As per the research study, Ionis Pharmaceuticals, Gilead Sciences, and Bristol-Myers Squibb are leading the worldwide market for anti-tumor drugs.

The main objective of this research is to provide a clear picture of the global anti-tumor drugs market to participants, stakeholders, and consultants and assist them in making crucial strategies for the further expansion of their businesses.

Full Research Report on Global Anti-tumor Drugs Market:

According to the most recent report by Renub Research, titled “Global Pork Market Forecast By Production, Consumption, Import, Export, Company” Pork is the most consumed meat within the world, and it accounts for 1/3 of the entire meat consumption globally. Asian region produces and consumes over half pig meat within the world. China is the biggest consumer of pig meat; Chinese living in a populated area with higher income prefer pig meat over other meat products. The outbreak of swine fever disrupted the availability of pig meat some years ago; currently, the world supply chain of pig meat is interrupted by COVID-19. consistent with Renub Research, Global Pork Market is expected to be US$ 191.2 Billion by 2026.

Pig meat is the most ordinarily consumed meat across the globe. About one-third of all meat consumed within the world is pork, before beef and chicken. the EU Union could be a significant pork producer. Around half the world’s pig meat is consumed in China, where urbanization and rising incomes still drive pork consumption upward.

Countries just like the ‘United States, Brazil, the European Union, and Chile are seeing boosts within the export of Pork. Currently, the United States’ pork production is growing at a rapid pace. Pork production in Asia is rapidly growing to become more self-sufficient just like the American and European continents. Growth in Pork consumption in Asia would lead to an increased demand for Pork. Most of the ECU and American countries are exporting Pork to China, like the USA, European Union, Brazil, and Chile. Currently, the USA is producing pig meat at a rapid pace.

Benefits of Pork: Pork meat has several health benefits thanks to the high quantity of protein present in it. it’s almost 26 percent of protein by weight. This protein is important for muscle growth and athletes recovering from injuries. Fat is additionally present in pork meat, and it contains 10-16 percent of fat. Pork also contains various vitamins and minerals like Thiamine; it’s beneficial for correct body functions. Selenium, Zinc, vitamin B12, vitamin B6, Niacin, Phosphorous, Iron, Creatine, Taurine, Glutathione also are present in high quantity in pork meat.

Impact of COVID-19 on Pig butcher shop

The pig butcher shop was suffering from African flu in previous years, now COVID-19 has broken the supply chain of pig meat. Most of the countries were in lockdown within the half of the year 2020, and other people are avoiding outdoors shopping.

The Philippines and Eastern Europe are currently seen because of the biggest hot spots when it involves ASF outbreaks. within the Philippines, ASF outbreaks are steady in Luzon backyard farms with a loss of around 98,000 pigs within the first four months of 2020. Rabobank forecasts a 12% decline in sow and total herds in 2020.

“While foodservice is now reopening in most parts of the planet, and lifting demand as a result, a return of 2019 demand levels is unlikely in 2020,” the report said. “The economic slowdown triggered by the COVID-19 pandemic has reduced consumer confidence, and that we expect prices will got to suits enable consumption to match availability.”

With the rapid decline in production capacity, pork prices still rise. To stabilize the local market, in March 2020, the Ministry of Agriculture and other governmental agencies released a group of policies to support the hog farming industry. Since many companies have announced aggressive new plans to extend production. consistent with the National Bureau of Statistics, the national pig inventory is 339.96 million head at the top of Q2, increasing by 5.8% over Q1. Among them, the sow inventory is now reported to be 36.29 million, which is a rise of 5.4% on a year-on-year basis, or up 7.3% over Q1.

The profitability of hog farming remains attractive and within the short term, there’s no sign of an easing up. Large amounts of capital have flown into the swine industry and since the second quarter, the quantity of newly registered swine companies has increased by 175% year on year.

Request a free Brochure copy of the report:

Market Summary:

By Producing Countries: This research report covers the following Pork producing countries: China, European Union, United States, Brazil, Russia, Vietnam, Canada, Mexico, Philippines, South Korea, and Other countries.

By Importing Countries: This research report covers the following Pork importing countries: Australia, South Korea, Canada, China, Mexico, Philippines, United States, Hong Kong, Japan, and Colombia.

By Exporting Countries: This research report covers the following Pork exporting countries: European Union, United States, Canada, Brazil, Chile, Mexico, China, Russia, Australia, and Serbia.

By Consuming Countries: This research report covers the following Pork consuming countries: China, the European Union, the United States, Brazil, Russia, Japan, Vietnam, Mexico, Philippines, and South Korea.

By Companies: This research report covers Overview, Initiatives & Recent Developments and Revenue analysis of Danish Crown, Tyson Foods Inc., Vion Food Group, and WH Group Limited.

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises of major players in Life Sciences, Information Technology, Telecom, Financial Services (Banking, Insurance), Energy, Retail, Manufacturing, Automotive, and Social sector. Our clients rely on our market analysis and data to make informed knowledgeable decisions. We are regarded as one of the best providers of knowledge. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions.

Contact Us:

Renub ResearchPhone No: +1 678-302-0700 (USA) | +91-120-421-9822 (IND)Email: info@renub.comWeb: Follow on Linkedin: